Evidence map›Paper›PMID 33134139›Full record

ArticleProcesses (Basel, Switzerland)2016

Modeling and Hemofiltration Treatment of Acute Inflammation.

Robert S Parker, Justin S Hogg, Anirban Roy, John A Kellum, Thomas Rimmelé, Silvia Daun-Gruhn, Morgan V Fedorchak, Isabella E Valenti, William J Federspiel, Jonathan Rubin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Processes (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Robert S ParkerDepartment of Chemical and Petroleum Engineering; Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Justin S HoggCarnegie Mellon-University of Pittsburgh Ph.D. Program in Computational Biology, 3501 Fifth Ave, 3064 BST3, Pittsburgh, PA 15260, USA.
Anirban RoyDepartment of Chemical and Petroleum Engineering; Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
John A KellumDepartment of Critical Care Medicine, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15213, USA.
Thomas RimmeléDepartment of Critical Care Medicine, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15213, USA.
Silvia Daun-GruhnDepartment of Critical Care Medicine, University of Pittsburgh Medical Center, 3550 Terrace St, Pittsburgh, PA 15213, USA.
Morgan V FedorchakDepartment of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Isabella E ValentiDepartment of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
William J FederspielDepartment of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Jonathan RubinDepartment of Mathematics, University of Pittsburgh, 301 Thackeray Hall, Pittsburgh, PA 15261, USA.
Yoram VodovotzMcGowan Institute for Regenerative Medicine, University of Pittsburgh Medical Center, 450 Technology Dr, Suite 300, Pittsburgh, PA 15219, USA.
Claudio LagoaDepartment of Surgery, University of Pittsburgh Medical Center, W944 Biomedical Sciences Tower, Pittsburgh, PA 15213, USA.
Gilles ClermontDepartment of Chemical and Petroleum Engineering; Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
University of Pittsburgh · USUniversity of Pittsburgh Medical Center · US

Funding

Systems Engineering of Pheresis Intervention for SepsisR01HL080926 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLUM, JOHN A · 2005 to 2009
$6.8M
Integrated Interdisciplinary, inter-university PhD Program Computational Biology (T32)T32EB009403 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BAHAR, IVET, BAR-JOSEPH, ZIV · 2009 to 2023
$4.4M
Model-Based Decisions in SepsisR01GM105728 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLERMONT, GILLES · 2014 to 2017
$1.1M
NHLBI NIH HHS R01 HL080926NIBIB NIH HHS T32 EB009403NIGMS NIH HHS R01 GM105728
6 · The paper itself

Abstract

The body responds to endotoxins by triggering the acute inflammatory response system to eliminate the threat posed by gram-negative bacteria (endotoxin) and restore health. However, an uncontrolled inflammatory response can lead to tissue damage, organ failure, and ultimately death; this is clinically known as sepsis. Mathematical models of acute inflammatory disease have the potential to guide treatment decisions in critically ill patients. In this work, an 8-state (8-D) differential equation model of the acute inflammatory response system to endotoxin challenge was developed. Endotoxin challenges at 3 and 12 mg/kg were administered to rats, and dynamic cytokine data for interleukin (IL)-6, tumor necrosis factor (TNF), and IL-10 were obtained and used to calibrate the model. Evaluation of competing model structures was performed by analyzing model predictions at 3, 6, and 12 mg/kg endotoxin challenges with respect to experimental data from rats. Subsequently, a model predictive control (MPC) algorithm was synthesized to control a hemoadsorption (HA) device, a blood purification treatment for acute inflammation. A particle filter (PF) algorithm was implemented to estimate the full state vector of the endotoxemic rat based on time series cytokine measurements. Treatment simulations show that: (i) the apparent primary mechanism of HA efficacy is white blood cell (WBC) capture, with cytokine capture a secondary benefit; and (ii) differential filtering of cytokines and WBC does not provide substantial improvement in treatment outcomes vs. existing HA devices.

Indexed as

cytokinesendotoxemiahemoadsorptioninflammationmathematical modelnonlinear MPCparticle filtersepsisstate estimation

Identifiers

PMID33134139
PMCPMC7596788
OpenAlexW2534053297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.